Research programme: peptide therapeutics - Nordic BioscienceAlternative Names: KBP 089
Latest Information Update: 25 Feb 2017
At a glance
- Originator Nordic Bioscience
- Class Peptides
- Mechanism of Action Amylin receptor agonists; Calcitonin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis